Roche Tissue Diagnostics delivers a comprehensive suite of validated immunohistochemistry and in situ hybridisation diagnostic solutions for breast cancer — so you can deliver the right test, with clinical confidence.
Our breast cancer predictive diagnostic offerings (HER2 IHC and ISH, ER, PR) in combination with our supporting diagnostic assays (Ki-67, p120 and E-cadherin) are fully automated on VENTANA BenchMark systems, which reduces the time to result and resources required compared to manual or semiautomated solutions.
INFORM HER2 Dual ISH DNA Probe Cocktail assay
HER2 (4B5) Rabbit Monoclonal Antibody
Breast carcinoma INFORM HER2 Dual ISH DNA Probe Cocktail non-amplified; magnification: 40X
Breast carcinoma HER2 (4B5) positive Score: 3+; magnification: 40X.